Press Release

The HLA Typing Market worth $ 990.12 million by 2026

July, 2020

" COVID-19 Impact on HLA Typing Market, size, share, growth, and forecast 2020-2026 "

HLA Typing is a type of genetic test used to identify variations in the human being’s immune system to know whether a particular person is capable of donating organ(s) or performing transplantation. The test is not only used for organ transplants but also bone marrow cord blood transplantation. The HLA Typing market is snowballing during the forecast period, and the factors driving this market are increasing focus on the transplant diagnostic procedures. This also leads to the introduction of the technological advancements in the HLA Typing market. The increase in the public and private funding in target research activities, such as targeting a group of people who need transplantation, also support the market growth.

However, the HLA typing has unfavorable reimbursements for the target procedures, which is causing the hinders the market growth.  The technological transfer from non-molecular serological assays to gene-based HLA profiling and the public perception regarding organ transplants in the emerging countries are factors giving the scope for the market to expand globally.

Request for sample report @

The HLA Typing Market research report titled “HLA Typing Market By Product, by Technology, by Application, by End-Users, by Geography- Forecast up to 2026, gives a detailed analysis of the growth of this market.  

The HLA Typing Market report offers an analysis of key market players, including Thermo Fisher Scientific, Inc., Omixon, CareDx, Inc, QIAGEN N.V., Luminex, Biofortuna, Illumina, Bio-Rad Laboratories, Inc., Takara Bio, TBG Diagnostics Ltd., and F. Hoffman-La Roche Ltd.  

North America has well established medical devices in the HLA typing field. Among medical professionals, the adoption of improved transplant diagnostic technologies, including HLA typing, is high in this region. In addition, the large number of organ transplant procedures is performed, and advanced technologies in the field of the transplant diagnostics are the major factors driving the market in the North America region.

Access full report summary @ 

The report consists of 100+ Tables and 70+ charts depicting the in-depth market study and the impact analysis of COVID-19 by Vendor's name.

  • Technology-based market segments covered in the study include:
    • Molecular Assay Technologies
    • Non-molecular Assay Technologies
  • Application-based categories covered in the study are:
    • Diagnostic Applications
      • Antibody Screening
      • Chimerism Monitoring
      • Others
    • Research Applications
  • Product categories covered in the study are:
    • Reagents & Consumables
    • Instruments
    • Software & Services
  • Categories of end-users covered in the study are:
    • Independent Reference Laboratories
    • Hospitals & Transplant Centers
    • Research Laboratories & Academic Institutes
  • Geographic coverage of the study is:
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World
  • The competitive landscape in the study covers key players in the market.

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication